Research & Development

哥哥色哥哥去哥哥撸洪秀柱:国民党不能只知反“台独” 却不愿谈统一

發布時間︰

白門張啟人句雲︰“書為重看多折角,詩因待酌暫存雙。”陳古漁亦有句雲︰“卻恐好書輕看過,折將余頁待明朝。”哥哥色 哥哥去 哥哥撸

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.


Connect? Registries


The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo